Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma.

Brian A BooneSamantha PerkinsRupal BandiErnesto SantosKevin McCluskeyDavid L BartlettJames F Pingpank

Published in: Journal of surgical oncology (2018)

HAI of melphalan is safe and feasible for patients with metastatic ocular melanoma. Further study to determine the optimal utilization of this treatment approach is warranted.

Keyphrases

liver metastases
high dose
low dose
basal cell carcinoma
replacement therapy
optical coherence tomography